Skip to main content

stock

BCTX · BriaCell Therapeutics Corp.

What BriaCell Therapeutics Corp. reports to the SEC, read from its filings.

Open in the app

Price

The live BCTX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on BCTX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
8,699,787 as of 2026-06-09 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-131.0%
ROA
-113.3%

Health

Current ratio
7.1x
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-04-30; balance sheet at 2026-04-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-04-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$7.62M-$7.16M
10-Q filed 2026-06-09
2026-01-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$7.53M-$7.22M
10-Q filed 2026-03-10
2025-10-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$8.32M-$8.20M
10-Q filed 2025-12-11
2025-07-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$8.55M-$8.09M
10-K filed 2025-10-16
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-04-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$6.33M-$6.13M
10-Q filed 2026-06-09
2025-01-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$7.17M-$6.29M
10-Q filed 2026-03-10
2024-10-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$5.15M-$5.80M
10-Q filed 2025-12-11
2024-07-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$5.77M-$1.21M
10-K filed 2025-10-16
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assets
$27.07M
Equity
$23.41M

Balance as of 2026-04-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-07-31—-$27.20M-$26.31M—
2024-07-31—-$33.33M-$4.79M-$24.58M
2023-07-31—-$23.27M-$20.30M—
2022-07-31—-$15.29M-$26.84M—
2021-07-31—-$6.98M-$13.82M—

Company filings

2 offering filings in 12 months

events

  • Regulation FD disclosure

    Regulation FD disclosure
    Jun 268-K
  • Material agreement, Unregistered share sale, Other event

    Material agreementUnregistered share saleOther event
    Jun 28-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Mar 318-K
  • Shareholder vote results

    Shareholder vote results
    Mar 98-K
  • Other event

    Other event
    Feb 208-K
  • Material agreement, Other event

    Material agreementOther event
    Jan 158-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named BCTX, and the market events around them.

Sign in to see this

Board

The BCTX board could not be loaded.

Retry the BCTX board

nakagai

Signals on BCTX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the BCTX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

BriaCell Therapeutics Corp. (BCTX): SEC filings, financials and insider trades · Nakagai